Doxy-PEP Part II: Where Are We Now?
In this episode, Dr. Marguerite Urban and Dr. Daniela DiMarco pick up from the November 2023 episode of Conversations with CEI, where they talked about Doxy-PEP for the prevention of sexually transmit...
14 Maalis 202417min
Tackling Stigma with Compassion: Harm Reduction in Clinical Practice
Harm reduction is a set of practical strategies and ideas aimed at reducing negative consequences associated with drug use. It is also a movement for social justice build on a belief in, and respect f...
8 Helmi 202428min
RSV Vaccination in HIV Positive Adults
RSV vaccine for adults has recently become available and can protect against severe disease or death from one of the main causes of upper respiratory infections. HIV patients are asking if they should...
11 Tammi 202411min
We can do it! Improving access to care for transgender and gender diverse patients
Compared with the general population, transgender and gender diverse people are more likely to experience poor health outcomes, such as chronic health conditions, HIV, substance use, and mental illnes...
14 Joulu 202317min
What is Doxy-PEP? A Conversation about the Use of Doxycycline Post Exposure Prophylaxis to Prevent STIs
In this episode, Dr. Marguerite Urban and Dr. Daniela DiMarco discuss Doxy-PEP, a new tool for the prevention of bacterial STIs. Drs. Urban and DiMarco are infectious disease faculty members at the U...
9 Marras 202315min
Safe and Safer Supply for People Who Use Drugs
The United States is in the midst of an overdose crisis that’s been exacerbated by the COVID-19 pandemic and increased toxicity of the drug supply, largely a result of adulterants like fentanyl and ot...
12 Loka 202332min
REPRIEVE: Pitavastatin to Prevent Cardiovascular Disease in HIV
HIV patients are known to have up to a two-fold increase in heart-related events, compared with the general population. Could treatment with statins reduce this risk? Dr. Steven Fine, an infectious di...
14 Syys 202312min
